HomePRN • TSE
Profound Medical Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 3.71M | 84.42% |
Operating expense | 11.28M | 15.06% |
Net income | -5.33M | 38.43% |
Net profit margin | -143.97 | 66.61% |
Earnings per share | -0.29 | 49.60% |
EBITDA | -8.39M | 2.18% |
Effective tax rate | 4.27% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 54.91M | 109.48% |
Total assets | 70.23M | 59.78% |
Total liabilities | 9.81M | -22.93% |
Total equity | 60.42M | — |
Shares outstanding | 30.04M | — |
Price to book | 4.13 | — |
Return on assets | -38.94% | — |
Return on capital | -42.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -5.33M | 38.43% |
Cash from operations | -5.64M | 23.02% |
Cash from investing | — | — |
Cash from financing | 35.65M | 18,016.08% |
Net change in cash | 27.79M | 474.92% |
Free cash flow | -5.07M | -4.21% |
Previous close
$8.30
Day range
$8.01 - $8.44
Year range
$6.77 - $15.75
Market cap
250.53M CAD
Avg Volume
7.10K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
2008
Headquarters
Website
Employees
142